Oklahoma 2022 Regular Session

Oklahoma Senate Bill SB1464

Introduced
2/7/22  
Refer
2/8/22  
Report Pass
2/14/22  
Engrossed
3/10/22  
Refer
3/28/22  
Report Pass
4/6/22  
Enrolled
4/28/22  

Caption

Public health; requiring list of disorders on state newborn screening program to match federal Recommended Uniform Screening Panel to extent practicable. Effective date.

Impact

The enactment of SB1464 is anticipated to have a positive impact on state health laws by standardizing the approach to newborn screening. This alignment with federal guidelines not only promotes uniformity across the state but also potentially increases the effectiveness of public health initiatives aimed at reducing the incidence of preventable conditions. The bill will empower the State Commissioner of Health to develop and implement educational programs that inform medical professionals and the public about these disorders, which further emphasizes preventative healthcare strategies.

Summary

Senate Bill 1464 aims to amend the existing regulations surrounding public health, specifically focusing on newborn screening programs in the state of Oklahoma. This legislation requires that the list of disorders tested for in newborns align closely with the federal Recommended Uniform Screening Panel (RUSP) to the extent that it is practicable. By ensuring consistency with federal guidelines, the bill seeks to enhance the early detection of serious genetic and metabolic disorders, thereby allowing for timely interventions that can significantly reduce infant morbidity and mortality rates.

Sentiment

The overall sentiment surrounding SB1464 appears to be positive, especially among healthcare professionals and advocates for public health. Supporters view the legislation as a crucial step toward ensuring that all newborns receive the best possible start in life through early screening and treatment options. However, there may also be concerns regarding the resource allocation for implementing the recommended changes and ensuring that all healthcare facilities can effectively administer the new guidelines.

Contention

Notably, while there seems to be widespread support for the goals of SB1464, some stakeholders may contest aspects of its implementation. Issues such as funding, healthcare infrastructure readiness, and the capacity for healthcare providers to adapt to the new requirements could spark debate. Additionally, there may be points of contention around the potential need for state lawmakers to address any disparities in access to screening services across different regions of Oklahoma.

Companion Bills

No companion bills found.

Previously Filed As

OK SB207

Public health; establishing the Oklahoma Rare Disease Advisory Council; modifying requirements relating to newborn screening program. Effective date. Emergency.

OK HCR33

Requests a study concerning potential inclusion in the state's newborn screening panel of all disorders listed on the federal Recommended Uniform Screening Panel

OK HB1782

Newborn screening requirements; federal Recommended Uniform Screening Panel, evaluation, report.

OK HB927

Newborn screening program; include those conditions listed on the Recommended Uniform Screening Panel within three years after listing.

OK SB00223

An Act Concerning The Timeframe To Complete Newborn Health Screenings.

OK A829

Expands number of disorders included in newborn screening program.

OK SB00373

An Act Concerning Newborn Infant Health Screening.

OK SB00847

An Act Concerning Newborn Infant Health Screening.

OK SB1092

Relating to the screening of newborns for sickle-cell trait and other disorders by the Department of State Health Services.

OK HB4506

Relating to the screening of newborns for sickle-cell trait and other disorders by the Department of State Health Services.

Similar Bills

No similar bills found.